CHC Healthcare To announce that CHC’s 2022 Q2 consolidated financial statements had been approved to Board of Directors.
· Issued by CHC Healthcare Group
Close
Today's Information
Provided by: CHC Healthcare Group
SEQ_NO
1
Date of announcement
2022/08/02
Time of announcement
18:06:16
Subject
To announce that CHC's 2022 Q2 consolidated
financial statements had been approved to Board of
Directors.
Date of events
2022/08/02
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/08/02
2.Date of approval by the audit committee:2022/08/02
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):1298380
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):408963
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):197345
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):233173
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):193020
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):171492
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.06
11.Total assets end of the period (thousand NTD):12758916
12.Total liabilities end of the period
(thousand NTD):6553710
13.Equity attributable to owners of parent end of the
period (thousand NTD):5954244
14.Any other matters that need to be specified:None
